Community Financial Services Group LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,531 shares of the medical research company’s stock after acquiring an additional 141 shares during the period. Community Financial Services Group LLC’s holdings in Agilent Technologies were worth $206,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. McAdam LLC grew its position in Agilent Technologies by 3.1% in the 3rd quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock valued at $376,000 after acquiring an additional 77 shares in the last quarter. Brown Brothers Harriman & Co. grew its holdings in shares of Agilent Technologies by 13.5% in the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock valued at $96,000 after purchasing an additional 77 shares in the last quarter. Global Retirement Partners LLC increased its stake in Agilent Technologies by 3.2% during the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock worth $382,000 after buying an additional 79 shares during the period. Rovin Capital UT ADV lifted its holdings in Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock worth $750,000 after buying an additional 81 shares in the last quarter. Finally, Marshall Financial Group LLC boosted its position in Agilent Technologies by 1.0% in the 3rd quarter. Marshall Financial Group LLC now owns 8,243 shares of the medical research company’s stock valued at $1,224,000 after buying an additional 82 shares during the period. 87.42% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Agilent Technologies
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.26% of the company’s stock.
Agilent Technologies Stock Performance
Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The business had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the company posted $1.38 EPS. The business’s revenue was up .8% on a year-over-year basis. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.56 EPS for the current fiscal year.
Agilent Technologies Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st were paid a dividend of $0.248 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend was Tuesday, December 31st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.40%.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on A. Sanford C. Bernstein cut their price objective on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday, November 26th. Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and upped their price target for the stock from $135.00 to $145.00 in a report on Monday. Citigroup boosted their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. Wells Fargo & Company dropped their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a report on Monday, December 9th. Finally, JPMorgan Chase & Co. lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $144.38.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Stories
- Five stocks we like better than Agilent Technologies
- Conference Calls and Individual Investors
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- How to Short a Stock in 5 Easy Steps
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Find and Profitably Trade Stocks at 52-Week Lows
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.